Literature DB >> 12325311

TH1/TH2 cytokines in the central nervous system.

Dvora Sredni-Kenigsbuch1.   

Abstract

For the past 20 years it has become increasingly evident that cytokines play an important role in both the normal development of the brain, acting as neurotrophic factors, and in brain injuries. Although cytokines and their receptors are synthesized and expressed in the brain (normally at low levels), increased cytokine production levels are now associated with various neurological disorders. T lymphocytes are the cells responsible for coordinating the immune response and a major source of cytokines. Different cytokines induce different subsets of T cells or have different effects on proliferation within a particular subset. Recent studies suggest that the immune response is in fact regulated by the balance between Th1 and Th2 cytokines. These two pathways are often mutually exclusive, the one resulting in protection and the other in progression of disease. Various studies describe the function and production of proinflammatory cytokines in the central nervous system (CNS) and their role in health and disease. Inflammation is upregulated following activation of Th1 cells, whereas Th2 cells may play a significant role in downregulating Th1 proinflammatory responses in those instances in which there is overproduction of Th2 cytokines. Although both Th1 and Th2 cytokines may influence CNS functioning, most studies have so far dealt with proinflammatory cytokines, probably because they directly affect CNS cells and are thought to be implicated in CNS pathology. It is of interest that endogenous glucocorticoids also control Th1-Th2 balance, favoring Th2 cell development. This review presents the evidence that cytokines have important functions in the CNS, both during development and as a part of brain pathology. In particular, the author highlighted recent work that supports a major role for the so-called inflammatory cytokines, Th1, and the anti-inflammatory Th2 cytokines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325311     DOI: 10.1080/00207450290025725

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  16 in total

1.  Interferon-γ inhibits central nervous system myelination through both STAT1-dependent and STAT1-independent pathways.

Authors:  Wensheng Lin; Yifeng Lin
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

2.  Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6.

Authors:  Daniela L Krause; Jenny K Wagner; Agnes Wildenauer; Judith Matz; Elif Weidinger; Michael Riedel; Michael Obermeier; Rudolf Gruber; Markus Schwarz; Norbert Müller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-01-21       Impact factor: 5.270

3.  Estrogen alters baseline and inflammatory-induced cytokine levels independent from hypothalamic-pituitary-adrenal axis activity.

Authors:  Kai-Yvonne Shivers; Nicole Amador; Lisa Abrams; Deirtra Hunter; Shirzad Jenab; Vanya Quiñones-Jenab
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

4.  Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay.

Authors:  Michael R Pranzatelli; Elizabeth D Tate; Nathan R McGee; Jerry A Colliver
Journal:  J Interferon Cytokine Res       Date:  2013-05-09       Impact factor: 2.607

5.  T-bet is essential for the progression of experimental autoimmune encephalomyelitis.

Authors:  Narender Nath; Ratna Prasad; Shailendra Giri; Avtar K Singh; Inderjit Singh
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

6.  CpG-C immunotherapeutic efficacy is jeopardized by ongoing exposure to stress: potential implications for clinical use.

Authors:  Yael Goldfarb; Ben Levi; Liat Sorski; Dan Frenkel; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2010-07-23       Impact factor: 7.217

Review 7.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

8.  S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.

Authors:  Narender Nath; Osamu Morinaga; Inderjit Singh
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-21       Impact factor: 4.147

9.  Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.

Authors:  Niyaz Mohammadzadeh Honarvar; Mohammad Hossein Harirchian; Mina Abdolahi; Elahe Abedi; Sama Bitarafan; Fariba Koohdani; Feridoun Siassi; Mohammad Ali Sahraian; Reza Chahardoli; Mahnaz Zareei; Eisa Salehi; Maziyar Geranmehr; Ali Akbar Saboor-Yaraghi
Journal:  J Mol Neurosci       Date:  2016-04-28       Impact factor: 3.444

10.  Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population.

Authors:  Yuichiro Watanabe; Ayako Nunokawa; Masako Shibuya; Naoshi Kaneko; Hiroyuki Nawa; Toshiyuki Someya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.